Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R D J Radstake

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|February 6, 2008
Gene expression profiling in rheumatoid arthritis: current concepts and future directionsE J M Toonen, P Barrera, T R D J Radstake, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosisL van Bon, C Popa, R Huijbens, et al.
Journal of Immunological Methods|November 15, 2011
Systematic validation of specific phenotypic markers for in vitro polarized human macrophagesC A Ambarus, S Krausz, M van Eijk, et al.
Clinical and Experimental Rheumatology|September 29, 2015
Functionally active NKG2A-expressing natural killer cells are elevated in rheumatoid arthritis patients compared to psoriatic arthritis patients and healthy donorsS T A van Bijnen, M Cossu, M W H Roeven, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritisT R D J Radstake, M Svenson, A M Eijsbouts, et al.
Annals of the Rheumatic Diseases|July 17, 2004
Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritisA W T van Lieshout, P Barrera, R L Smeets, et al.
Annals of the Rheumatic Diseases|April 11, 2014
Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotypeL van Bon, M Cossu, A Loof, et al.
Annals of the Rheumatic Diseases|August 28, 2004
Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptorsT R D J Radstake, R van der Voort, M ten Brummelhuis, et al.
Annals of the Rheumatic Diseases|September 13, 2011
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.
Arthritis and Rheumatism|July 30, 2005
The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cellsM F Roelofs, L A B Joosten, S Abdollahi-Roodsaz, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|February 6, 2008
Gene expression profiling in rheumatoid arthritis: current concepts and future directionsE J M Toonen, P Barrera, T R D J Radstake, et al.
Annals of the Rheumatic Diseases|May 26, 2010
Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosisL van Bon, C Popa, R Huijbens, et al.
Journal of Immunological Methods|November 15, 2011
Systematic validation of specific phenotypic markers for in vitro polarized human macrophagesC A Ambarus, S Krausz, M van Eijk, et al.
Clinical and Experimental Rheumatology|September 29, 2015
Functionally active NKG2A-expressing natural killer cells are elevated in rheumatoid arthritis patients compared to psoriatic arthritis patients and healthy donorsS T A van Bijnen, M Cossu, M W H Roeven, et al.
Annals of the Rheumatic Diseases|November 21, 2008
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritisT R D J Radstake, M Svenson, A M Eijsbouts, et al.
Annals of the Rheumatic Diseases|July 17, 2004
Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritisA W T van Lieshout, P Barrera, R L Smeets, et al.
Annals of the Rheumatic Diseases|April 11, 2014
Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotypeL van Bon, M Cossu, A Loof, et al.
Annals of the Rheumatic Diseases|August 28, 2004
Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptorsT R D J Radstake, R van der Voort, M ten Brummelhuis, et al.
Annals of the Rheumatic Diseases|September 13, 2011
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.
Arthritis and Rheumatism|July 30, 2005
The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cellsM F Roelofs, L A B Joosten, S Abdollahi-Roodsaz, et al.
Pageof 5